AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19216446
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate (bolus 50 mg/kg and 0.5 g/h)
Trial: 22395054
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution (control group)
Trial: 18691778
Drug: Normal potassium
RxNorm normalized name: Potassium
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal potassium (4-4.9 mEq/L)
Trial: 18691778
Drug: Low-normal potassium
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-normal potassium (3.5-3.9 mEq/L)
Trial: 16551916
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia (continuous naropine infusion)
Trial: 9457283
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with the Dornier Urowave device
Trial: 9141923
Drug: ORG 9487
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORG 9487 (up to 2.0 mg/kg for adults, up to 1.5 mg/kg for elderly)
Trial: 19625715
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine
Trial: 17076982
Drug: IM aripiprazole
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: IM aripiprazole 9.75 mg
Trial: 19111849
Drug: IM aripiprazole
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: IM aripiprazole 15 mg
Trial: 9796594
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy (20 minutes daily for 1 month)
Trial: 8035026
Drug: SPf66 malaria
RxNorm normalized name: PLASMODIUM MALARIAE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPf66 malaria vaccine (three doses on days 0, 20, and 112)
Trial: 24395557
Drug: Chondroitin sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulfate 800 mg
Trial: 6433769
Drug: HB 419
RxNorm normalized name: Citalopram Hydrobromide
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HB 419 (5 mg)
Trial: 2083404
Drug: Choline magnesium
RxNorm normalized name: Choline Magnesium Trisalicylate
DrugBank: Choline (DB00122)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Choline magnesium trisalicylate (CMT, trilisate) pre-treatment
Trial: 14699020
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (0.8 mg), vitamin B12 (0.4 mg), and vitamin B6 (40 mg)
Trial: 21389855
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (0.8 mg) and vitamin B12 (0.4 mg)
Trial: 11929645
Drug: Both contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both contraceptive treatments
Trial: 26175027
Drug: TDEN vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TDEN vaccine (two formulations)
Trial: 8259754
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol therapy (Estraderm 50 micrograms/24h)
Trial: 7707852
Drug: Ringer's solution
RxNorm normalized name: Ringer's solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer's solution
Trial: 10883747
Drug: Inhaled albuterol
RxNorm normalized name: albuterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled albuterol (180 microg four times daily for 7 days)
Trial: 26026121
Drug: Weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly docetaxel (36 mg/m2, days 1 and 8)
Trial: 12802750
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with lamivudine (100 mg daily) and IFN‐alpha‐2b (10 million U 3 times per week for 12 months)
Trial: 9256568
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch (TNP; 21 mg)
Trial: 9256568
Drug: Self-help treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-help treatment manual only
Trial: 8476802
Drug: 45 min
RxNorm normalized name: ZINC OXIDE 19 g in 100 mL TOPICAL LOTION [Meadow and Bark SPF 45 Mineral Sport Sunscreen]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 min incremental oxytocin infusion
Trial: 23196892
Drug: Spinal anaesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anaesthesia (SPA) with 7.5 mg hyperbaric bupivacaine
Trial: 23196892
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anaesthesia (TIVA) with Propofol and Fentanyl
Trial: 9382539
Drug: Intra-arterial infusion
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial infusion chemotherapy with 5-FU + MMC +/- ADR (Group I)
Trial: 9382539
Drug: Intra-arterial infusion
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial infusion chemotherapy in primary cases
Trial: 9382539
Drug: All cases
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All cases of intra-arterial infusion chemotherapy
Trial: 9382539
Drug: Intra-arterial infusion
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial infusion chemotherapy with catheter tip in internal iliac arteries
Trial: 8566980
Drug: Podophyllotoxin solution
RxNorm normalized name: podophyllotoxin
DrugBank: Podofilox (DB01179)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Podophyllotoxin solution 0.5% (Condyline)
Trial: 1173042
Drug: Xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylidide)
RxNorm normalized name: xipamide
DrugBank: Xipamide (DB13803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylidide) administered orally in doses ranging from 0.035 to 0.750 mg/kg body weight
Trial: 29187186
Drug: Current DM
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Current DM treatment standards (Control)
Trial: 9613683
Drug: Filgrastim 5
RxNorm normalized name: Filgrastim
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Filgrastim 5 microg/kg/dy after intensive sequential chemotherapy
Trial: 27759930
Drug: Intermittent Cyclical
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent Cyclical Etidronate Therapy
Trial: 2905256
Drug: roxatidine acetate
RxNorm normalized name: roxatidine acetate
DrugBank: Roxatidine acetate (DB08806)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxatidine acetate 75 mg twice daily
Trial: 19951520
Drug: Nasal inhaled
RxNorm normalized name: Nasal Inhalant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal inhaled corticosteroid (ICS) through a spacer with mask (budesonide inhaler 400 microg/d)
Trial: 19951520
Drug: Orally inhaled
RxNorm normalized name: Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally inhaled budesonide dry powder (400 microg/d) plus nasal spray of budesonide aquae (256 microg/d)
Trial: 15364229
Drug: Loteprednol etabonate
RxNorm normalized name: Loteprednol Etabonate
DrugBank: Loteprednol etabonate (DB14596)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Loteprednol etabonate ophthalmic suspension, 0.5%, 4 times a day for 4 weeks
Trial: 10867675
Drug: Residual of
RxNorm normalized name: antihemophilic factor, human recombinant residues 743-1636 deleted Injection [Xyntha]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Residual of the regression of actual treatment indicator on randomization arm indicator
Trial: 31706541
Drug: Autologous platelet-rich
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous platelet-rich gel (APG)
Trial: 5441886
Drug: Intravenous secretin
RxNorm normalized name: Secretin
DrugBank: Secretin human (DB09532)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous secretin (2 units per kilogram per hour)
Trial: 3070179
Drug: Intramuscular emulsified
RxNorm normalized name: diazepam
DrugBank: Diazepam (DB00829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular emulsified disulfiram (1 g in soybean emulsion)
Trial: 25500831
Drug: Oral disulfiram
RxNorm normalized name: Disulfiram
DrugBank: Disulfiram (DB00822)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral disulfiram
Trial: 16200718
Drug: Percutaneous estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Percutaneous estradiol gel (0.75 mg of 17 beta‐estradiol/d) + medroxyprogesterone acetate (2 mg/d) in group 4 (G4)
Trial: 16544586
Drug: Traditional up-dosing
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional up-dosing scheme
Trial: 12865191
Drug: Dermal HRT
RxNorm normalized name: Dermal-Soothe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermal HRT (17 beta‐oestradiol gel with oral progestogen)
Trial: 28557736
Drug: Intervention schools
RxNorm normalized name: cetylpyridinium chloride Topical Spray [Rocco's Old School]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention schools with increased opportunities for risk and challenge (e.g., rough-and-tumble play, reduced rules, added loose parts)
Trial: 22339102
Drug: Acupuncture-like transcutaneous
RxNorm normalized name: insulin-like growth factor 2
DrugBank: Insulin-like growth factor II (DB14472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture-like transcutaneous electrical nerve stimulation (AL-TENS) at Hegu (LI4) and Sanyinjiao (SP6) points, applied twice weekly for 8 weeks.
Trial: 1590373
Drug: Lipid study
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid study (infusion of lipid emulsion to meet resting energy requirements during 84‐h oral fast)
Trial: 1590373
Drug: Control study
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control study (84 h fasting without lipid infusion)
Trial: 2197382
Drug: Rectal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Rectal midazolam 0.25 mg/kg
Trial: 26103129
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (200 mg daily for 8 weeks)
Trial: 21953602
Drug: Acute cortisol
RxNorm normalized name: cortisol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute cortisol (30 mg hydrocortisone)
Trial: 22883020
Drug: Intravenous sedation
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous sedation with propofol
Trial: 9649976
Drug: 5-day lofexidine
RxNorm normalized name: LOFEXIDINE
DrugBank: Lofexidine (DB04948)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-day lofexidine treatment
Trial: 8206771
Drug: Procedural modeling
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Procedural modeling video treatment
Trial: 16765759
Drug: Oral anticoagulation
RxNorm normalized name: monitoring agent for oral anticoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulation therapy (target international normalised ratio of 2.0-3.0)
Trial: 25211216
Drug: SAP therapy
RxNorm normalized name: Bambusa vulgaris sap extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAP therapy (sensor-augmented pump therapy)
Trial: 14963679
Drug: Occupational integrated
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Occupational integrated rehabilitation program (2.5-3 hours twice a week for 15 weeks according to BAR guidelines) with annual check-ups.
Trial: 18689571
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g resistant maltodextrin
Trial: 20169858
Drug: Levocetirizine dihydrochloride
RxNorm normalized name: Levocetirizine Dihydrochloride
DrugBank: Levocetirizine (DB06282)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levocetirizine dihydrochloride orally disintegrating tablets
Trial: 21584681
Drug: Carbohydrate supplementation
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate supplementation (maltodextrin solution)
Trial: 20369059
Drug: Virosomal vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virosomal vaccine (SVV)
Trial: 19342599
Drug: Intralipid injection
RxNorm normalized name: Intralipid Injectable Product
DrugBank: Soybean oil (DB09422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralipid injection
Trial: 11140431
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 500 microg administered via Diskus or Diskhaler for 12 weeks
Trial: 7917442
Drug: Daily alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daily alcohol consumption
Trial: 30922997
Drug: Budesonide orodispersible
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide orodispersible tablet (BOT) 1 mg twice daily; n = 59
Trial: 15104206
Drug: Oestradiol valerate
RxNorm normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oestradiol valerate therapy
Trial: 30598343
Drug: GLP-1 infusion
RxNorm normalized name: Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 infusion
Trial: 11069197
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg alendronate daily (group 2)
Trial: 11069197
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg alendronate daily (group 1)
Trial: 6203784
Drug: Hormone determinations
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone determinations
Trial: 15567810
Drug: midazolam 2
RxNorm normalized name: midazolam 2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: midazolam 2 mg
Trial: 31789723
Drug: Radioiodine ablation
RxNorm normalized name: Radioiodine
DrugBank: Iodide I-131 (DB09293)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioiodine ablation (RAI) with higher weight-based doses of I-131 (250 μCI/g thyroid tissue)
Trial: 31789723
Drug: Maternal or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal or neonatal TSH receptor antibodies and TSH at 3-7 days of age
Trial: 19070418
Drug: Tolterodine ER
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine ER 4 mg per day
Trial: 30591031
Drug: Valerian capsules
DrugBank: Valerian (DB13196)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valerian capsules taken 60 minutes before bedtime for one month
Trial: 16816926
Drug: Ospemifene 30
RxNorm normalized name: Ospemifene
DrugBank: Ospemifene (DB04938)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ospemifene 30 mg
Trial: 10516537
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg b.i.d. orally for 14 days (CL group)
Trial: 10516537
Drug: Clarithromycin plus
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin plus cefuroxime 500 mg b.i.d. orally for 7 days (CLCE group)
Trial: 7488598
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg oral acetazolamide
Trial: 2661242
Drug: Conventional naproxen
RxNorm normalized name: Naproxen
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional naproxen capsules (500 mg twice daily)
Trial: 6118983
Drug: Sudden cancellation
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sudden cancellation of psychotropic drugs (with modifications such as combinations with sulfozine and diuretics)
Trial: 30839405
Drug: Regular insulin
RxNorm normalized name: Regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular insulin bolus with glucose infusion (Group A; n = 20)
Trial: 1800877
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of fentanyl combined with diazepam (greater than that used in Group I)
Trial: 23989106
Drug: 10-day amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-day amoxicillin (80 mg/kg/d; divided into 3 daily doses)
Trial: 23989106
Drug: 5-day amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-day amoxicillin (80 mg/kg/d; divided into 3 daily doses)
Trial: 23989106
Drug: 3-day amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-day amoxicillin (80 mg/kg/d; divided into 3 daily doses)
Trial: 3555062
Drug: Intravenous ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ciprofloxacin 300 mg every 12 hours
Trial: 3555062
Drug: Ciprofloxacin orally
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin orally after initial intravenous therapy
Trial: 2686417
Drug: Intravenous ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ciprofloxacin
Trial: 8624384
Drug: Systemically active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemically active antifungals
Trial: 21072892
Drug: Granulocyte colony
RxNorm normalized name: Granulocyte colony stimulating factor
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Granulocyte colony stimulating factor for five days followed by autologous CD34(+) and CD133(+) stem cell infusion in the portal vein
Trial: 15772912
Drug: Alvimopan 1
RxNorm normalized name: alvimopan 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alvimopan 1 mg
Trial: 2373139
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg suppository
Trial: 2373139
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 5 mg oral tablets
Trial: 16555564
Drug: 100 mL
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mL of contrast material alone (group A)
Trial: 21029339
Drug: Thiazide diuretics
RxNorm normalized name: althiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiazide diuretics
Trial: 17078309
Drug: Nicotine (NIC)
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine (NIC) using a 21-mg transdermal patch
Trial: 2210865
Drug: IgG-anti-LPS therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgG-anti-LPS therapy (more than 65 micrograms/ml)
Trial: 1992998
Drug: Intravenous IgG
RxNorm normalized name: Human IGG
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous IgG
Trial: 19501215
Drug: etravirine 200
RxNorm normalized name: etravirine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etravirine 200 mg bid coadministered with ethinylestradiol/norethindrone
Trial: 15070596
Drug: Chemotherapy for
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy for recurrent disease
Trial: 29187901
Drug: First-line platinum-based
RxNorm normalized name: platinum
DrugBank: Platinum (DB12257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First-line platinum-based doublet chemotherapy
Trial: 21774826
Drug: Artemether-lumefantrine (AL)
RxNorm normalized name: ARTEMETHER/LUMEFANTRINE
DrugBank: Lumefantrine co-artemether (DB13085)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artemether-lumefantrine (AL) given twice a day for three days